The annual report lays out our income and expenditure for the year, as well as highlighting some of our key achievements. You can download PDF versions of our latest reports below.
Ascend, funded by UK aid, aims to deliver more than 400 million treatments to treat and prevent five NTDs across 13 countries. And through Accelerate, we will continue our fight towards trachoma elimination as several of our other trachoma programmes came to a close.
In our eye health portfolio, we saw the enormous accomplishment of halving blindness in the Sundarbans, an island region in India where 40 per cent of the population live in poverty and eye care was difficult to access. You can read more about some of our highlights in the Spotlights document.
We recorded our highest ever income in 2019: a total of £341 million, and non-gift-in-kind income surpassed £100m for the first time.
2018 was a momentous year for Sightsavers. We unveiled two groundbreaking disability inclusion programmes – Inclusion Works and Disability Inclusive Development – and signed a huge new contract for the Accelerate Trachoma Elimination Programme, backed by a $105 million philanthropy fund, which aims to eliminate trachoma in at least 10 countries.
Our work in Ghana helped it to become the first sub-Saharan country to eliminate trachoma as a public health problem. This shows that eliminating trachoma is possible, paving the way for many other countries to follow.
It was a record year for Sightsavers’ voluntary income, with our Christmas mailing raising more than £1 million. We also forged a partnership with People’s Postcode Lottery that has so far raised £1.1 million, with more draws to come in 2019.
In 2017, we celebrated a historic milestone: we delivered our one billionth treatment to people affected by painful neglected tropical diseases. We also reached our Million Miracles fundraising target to raise £30 million to fund sight-saving operations in some of the poorest parts of the world.
During the year we applied for the Audacious Project, an initiative overseen by TED to turn transformative ideas into action, and we were delighted to be chosen to receive substantial funds to help us end trachoma. Sightsavers CEO Caroline Harper gave a TED Talk discussing our ambitious plan to eliminate the disease.
Other highlights include Professor Stephen Hawking speaking at our event to celebrate our NTDs milestone, in what was to be his last public engagement.
During 2016 we continued our work against neglected tropical diseases, with more than 154 million treatments distributed during the year as we approached the cumulative milestone of a billion treatments. Meanwhile, Sightsavers’ overall income increased to more than £300 million for the first time.
2016 was the final year for DFID Programme Partnership Agreements, and we’re pleased to have been given an A+ rating for our work during the five years of the partnership. We also received an A+ assessment for our DFID-funded Nigerian NTD programme, known as UNITED.
Our supporter care team were rewarded for their hard work: we were given first prize in the charity sector in the Top 50 Customer Service Awards.
The Sustainable Development Goals were agreed at the UN, marking a huge leap forward for people with disabilities. These 17 global goals, to be adopted by UN member states, aim to end all forms of poverty, fight inequalities and tackle climate change, while ensuring that no one is left behind.
Sightsavers’ Global Trachoma Mapping Project, the largest infectious disease survey ever undertaken, was completed at the end of 2015. It aimed to pinpoint the world’s trachoma-endemic areas: during the three-year project, surveyors collected data from 2.6 million people in 29 countries using smartphones.
During the year we also enjoyed unprecedented media coverage, with Sightsavers featuring on Channel 4’s Unreported World, the MailOnline and BBC Radio 5.